AiCME - Targeted adjuvant strategies for HR-positive HER2-negative early breast cancer: Who can benefit, and how can we optimize their use?

Questions and take-home messages (ID 503)

Lecture Time
12:30 - 12:30
Room
Hamburg Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • All Speakers (na, Switzerland)
Authors
  • All Speakers (na, Switzerland)